Thermo Scientific™ VACC Agar (w/vancomycin amphotericin B, ceftazidime, and clindamycin)

Description

• Carry out primary, selective isolation of extended-spectrum-beta-lactamase producing Enterobacteriaceae in qualitative procedures with Thermo Scientific™ Remel™ VACC Agar (w/vancomycin amphotericin B, ceftazidime, and clindamycin)
• Extended Spectrum β Lactamases are enzymes capable of conferring bacterial resistance to penicillins, cephalosporins, and aztreonam by hydrolysis of these antibiotics 1,2
• Production of ESBLs is a significant resistance-mechanism that impedes the antimicrobial treatment of infections caused by Enterobacteriaceae and is a serious threat to the currently available antibiotic armory 3
• The medium can facilitate earlier identification of colonized patients and can help reduce the cost of surveillance screening
• Selective: selective agents vancomycin, amphotericin B, ceftazidime, and clindamycin inhibit many commensal organisms found in the large intestine while at the same time allowing the growth of certain resistant organisms
• Facilitates earlier identification of colonized patients and can help reduce the cost of surveillance screening
• Ready to use convenience of prepared media
• In a study conducted from 2000 to 2005, there were 17,872 inpatients screened for rectal colonization with ESBL-producing Enterobacteriaceae
• The colonization rate doubled during this study 4 .During the same study cited above, 8.5% of colonized patients developed a subsequent bloodstream infection 4
• Surveillance screening is useful for infection control and antimicrobial stewardship in controlling the proliferation of ESBL-producing bacteria
• The use of VACC Agar can facilitate earlier identification of colonized patients and can help reduce the cost of surveillance screening
• Not all products are available for sale in all territories
• Please inquire
• Remel™ and Oxoid™ products are now part of the Thermo Scientific brand